• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Peptides
• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Peptides

Recent Advances in the Study of H-HIS-SER-OH (CAS: 21438-60-8) in Chemical Biology and Pharmaceutical Research

The dipeptide H-HIS-SER-OH (CAS: 21438-60-8) has recently garnered significant attention in chemical biology and pharmaceutical research due to its potential therapeutic applications and unique biochemical properties. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activity, and potential clinical applications. Recent studies have highlighted its role in modulating enzymatic activity and its utility as a building block in peptide-based drug design.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated that H-HIS-SER-OH exhibits notable stability under physiological conditions, making it a promising candidate for oral drug formulations. The research team employed advanced NMR spectroscopy and mass spectrometry to characterize its structural dynamics, revealing a unique hydrogen-bonding network that contributes to its stability. These findings open new avenues for its use in peptide therapeutics, particularly in diseases where enzymatic degradation of peptides is a major challenge.

In the context of neurodegenerative diseases, a recent preclinical study investigated the neuroprotective effects of H-HIS-SER-OH. The compound showed significant potential in reducing oxidative stress in neuronal cells, with a 40% reduction in reactive oxygen species observed at therapeutic concentrations. This effect was attributed to the compound's ability to chelate metal ions and scavenge free radicals, properties derived from its histidine moiety. These results suggest potential applications in Alzheimer's and Parkinson's disease treatment strategies.

From a synthetic chemistry perspective, novel methodologies for the large-scale production of H-HIS-SER-OH have been developed. A 2024 Nature Communications paper described a continuous flow synthesis approach that improved yield by 35% compared to traditional batch methods while reducing environmental impact through solvent minimization. This technological advancement addresses previous scalability challenges and could facilitate broader research and potential commercialization of this compound.

The immunomodulatory properties of H-HIS-SER-OH have also been explored in recent studies. Research published in Cell Chemical Biology demonstrated its ability to modulate T-cell responses through interaction with specific histamine receptors. This finding has sparked interest in developing H-HIS-SER-OH derivatives as potential treatments for autoimmune disorders, with preliminary in vivo studies showing promising results in mouse models of rheumatoid arthritis.

Looking forward, the unique combination of stability, bioactivity, and synthetic accessibility positions H-HIS-SER-OH as a versatile scaffold for drug development. Current research efforts are focusing on structure-activity relationship studies to optimize its therapeutic potential while minimizing off-target effects. The compound's dual functionality, combining the properties of histidine and serine, continues to make it a valuable subject of study in both academic and industrial research settings.

• 2578-58-7((S)-2-(2-Amino-3-(1H-imidazol-4-yl)propanamido)acetic acid)
• 126828-32-8(L-Alanyl-L-histidyl-L-lysine)
• 3253-17-6(L-Alanyl-L-histidine)
• 147732-56-7(Palmitoyl Tripeptide-1)
• 2489-13-6((S)-2-(2-Aminoacetamido)-3-(1H-imidazol-4-yl)propanoic acid)
• 49557-75-7(Glycyl-l-histidyl-l-lysine)
• 347884-61-1(Glycine,L-histidylglycyl-L-valyl-L-serylglycyl-L-histidylglycyl-L-glutaminyl-L-histidylglycyl-L-valyl-L-histidyl-)
• 3650-73-5((2S)-2-(4-aminobutanamido)-3-(1H-imidazol-4-yl)propanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)